Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer
Phase 2 Completed
41 enrolled 9 charts
Cisplatin vs Paclitaxel for Triple Negative Breast Cancer
Phase 2 Completed
147 enrolled 15 charts
KEYVIBE-005
Phase 2 Completed
613 enrolled
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Phase 2 Completed
344 enrolled
Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa
Phase 2 Completed
118 enrolled 23 charts
IVY
Phase 1 Completed
353 enrolled
PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
Phase 2 Completed
135 enrolled 14 charts
CANFOUR
Phase 1/2 Completed
167 enrolled
Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors
Phase 1 Completed
71 enrolled
TAK-228 and TAK-117 Followed by Cisplatin and Nab Paclitaxel for Metastatic Triple Negative Breast Cancer
Phase 2 Completed
12 enrolled 11 charts
PIVOT-02
Phase 1/2 Completed
557 enrolled 22 charts
A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)
Phase 1 Completed
110 enrolled 80 charts
ARCS-Multi
Phase 1 Completed
173 enrolled
A Study of LY3023414 in Participants With Advanced Cancer
Phase 1 Completed
156 enrolled
CISPLATIN + AZD-1775 In Breast Cancer
Phase 2 Completed
34 enrolled 9 charts
Cisplatin + RT for Triple Negative Breast Cancer
Phase 1 Completed
55 enrolled
Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer
Phase 2 Completed
51 enrolled 7 charts
High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer
Phase 3 Completed
224 enrolled
A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer
Phase 1 Completed
167 enrolled
A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin
Phase 2 Completed
35 enrolled 23 charts
Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer
Phase 3 Completed
184 enrolled
Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer
Phase 1/2 Completed
55 enrolled 12 charts
Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase 2 Completed
48 enrolled 10 charts
Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer
Phase 2 Completed
10 enrolled 9 charts
Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors
Phase 1 Completed
9 enrolled
Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
16 enrolled
Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer
Phase 1 Completed
50 enrolled
BERNAQ
Phase 2 Completed
30 enrolled
Preoperative Cisplatin in Early Stage Breast Cancer
Phase 2 Completed
27 enrolled
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase 2 Completed
59 enrolled
High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer
Phase 1 Completed
33 enrolled
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
Phase 2 Completed
145 enrolled 10 charts
TNBC
Phase 3 Completed
240 enrolled
Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast Cancer
Phase 2 Completed
94 enrolled
BALI-1
Phase 2 Completed
181 enrolled 15 charts
Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal Metastasis
Phase 2 Completed
40 enrolled
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer
Phase 2 Completed
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer
Phase 2 Completed
Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer
Phase 1 Completed
18 enrolled
A Combination of Abraxane and Cisplatin in Metastatic Breast Cancer
Phase 2 Completed
73 enrolled
Cisplatin
Phase 2 Completed
20 enrolled
Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer
Phase NA Completed
10 enrolled
Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
48 enrolled
Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1 Completed
Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors
Phase 2 Completed
20 enrolled
Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast Cancer
Phase 2 Completed
141 enrolled
Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer
Phase 2 Completed
65 enrolled 13 charts
Combination Chemotherapy in Treating Patients With Metastatic Breast Cancer
Phase 2 Completed
36 enrolled
Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast Cancer
Phase 2 Completed
20 enrolled
Combination Chemotherapy for Metastatic Breast Cancer
Phase 2 Completed
70 enrolled 18 charts